On May 24, 2010
NIH Conflict of Interest Proposal Dodges Pharma’s Control of Research
The NIH proposal to address grantees’ financial conflicts of interest fails to address the real problem: pharmaceutical companies’ corruption of clinical research.
No tags for this post.
0 Comments